Metformin is a drug that is used primarily to lower blood sugar in prediabetes or diabetes. In recent years research continues to show benefits for arresting cancer cell growth as well.
Metformin affects multiple key processes related to cell growth, proliferation, and survival through a number rof pathways.
Metformin decreases the amount of glucose produced by the liver and reduces the bloodstream level and cellular uptake of insulin. The reduced insulin stimulation results in reduced activation of insulin receptors on cell membranes, triggering a cascade of intracellular molecular pathways that may be activated in different types of cancer cells.
At this point we recommend it to most cancer patients.